GRI Bio to Showcase Innovative Therapies at European Congress
![GRI Bio to Showcase Innovative Therapies at European Congress](https://investorshangout.com/images/blog/ihnews-GRI%20Bio%20to%20Showcase%20Innovative%20Therapies%20at%20European%20Congress.jpg)
GRI Bio to Present at the 2024 European Respiratory Congress
LA JOLLA, CA – GRI Bio, Inc. (NASDAQ: GRI) is making waves in the biotechnology field with its innovative approach to treating a range of diseases, including inflammatory, fibrotic, and autoimmune conditions. The Company has announced that its abstract has been accepted for a poster presentation at the upcoming 2024 European Respiratory Congress (ERS), which will be held from September 7 to 11 in Vienna, Austria.
Details of the Presentation
During this prestigious event, GRI Bio will showcase pivotal research through the following poster presentation:
- Title: Type 1 Invariant Natural Killer T Cells Drive Lung Fibrosis
- Presenter: Emily Calamita from Dr. Adam Byrne's laboratory, Imperial College London
- Poster Number: PA3381
- Session: Novel Insights in the Pathogenesis of Pulmonary Fibrosis
- Date and Time: September 9, 2024, from 12:30 - 2:00 PM CEST
Understanding GRI Bio's Focus on NKT Cells
GRI Bio is pioneering advancements in biopharmaceuticals, specifically targeting Natural Killer T (NKT) cell modulators. These therapeutic approaches are designed to tackle the root causes of diseases by regulating NKT cells, which play a central role in the body’s inflammatory response. By focusing on these cells, GRI Bio aims to alter disease progression and restore the immune system's balance.
The Role of NKT Cells in Disease
NKT cells serve as a functional bridge between innate and adaptive immunity. Type 1 invariant (iNKT) cells, in particular, are crucial in managing inflammation and fibrosis in various diseases. Their modulation could lead to groundbreaking treatments for conditions such as idiopathic pulmonary fibrosis (IPF), a severe illness that currently lacks effective therapies.
GRI Bio's Pipeline and Future Endeavors
The Company's flagship development is GRI-0621, an inhibitor targeting iNKT cell activity, designed to offer a novel oral therapeutic solution for idiopathic pulmonary fibrosis. Furthermore, GRI Bio is also engaged in developing type 2 NKT agonists aimed at treating systemic lupus erythematosus. With an extensive library of over 500 proprietary compounds, GRI Bio is well-positioned to expand its innovative therapeutic pipeline.
Investor Relations and Contact Information
For further inquiries and insights on GRI Bio, investors and interested parties can reach out to the investor relations team:
Contact:
JTC Team, LLC
Jenene Thomas
(833) 475-8247
GRI@jtcir.com
Frequently Asked Questions
What is GRI Bio, Inc. focused on?
GRI Bio is a biotechnology company specializing in therapies targeting Natural Killer T (NKT) cells for the treatment of inflammatory, fibrotic, and autoimmune diseases.
Where and when will GRI Bio present its research?
GRI Bio will present its research at the 2024 European Respiratory Congress in Vienna, Austria, on September 9, 2024.
What is the title of GRI Bio's poster presentation?
The title is 'Type 1 Invariant Natural Killer T Cells Drive Lung Fibrosis.'
Who is presenting the poster?
Emily Calamita from Dr. Adam Byrne's laboratory at Imperial College London will be presenting the poster.
What is GRI-0621?
GRI-0621 is GRI Bio's lead program aimed at inhibiting iNKT cell activity, being developed as a novel oral therapeutic for idiopathic pulmonary fibrosis.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
Related Articles
- Felo AI Launch: Transforming Search with Language Innovation
- The Abbey Food & Bar Earns Safe Space Certification from SIGBI
- College of Charleston Unveils Renovated Albert Simons Center
- ASLA Unveils Transformative 2024 Professional Awards Winners
- Growth of the Packaging Automation Market Towards 2032
- Chemical Injection Pumps Market Growth Expected at 8.4% CAGR
- Projected Growth of Conductive Polymer Coating Market
- Earn Alliance Appoints Jeff Drobick as New COO to Enhance Growth
- Discover Rocko: Your Gateway to Crypto-Backed Loans
- Endeavour Mining Updates on Major Shareholder Notification
- Vishay Intertechnology Expands Haptic Feedback Actuators Range
- Moon Gaming Inc. Unveils Moon Poker: Exciting Tournaments Ahead
- J.P. Morgan Enhances Morgan Money with Kyriba Integration
- Trump Hotels Enhances Operations with BirchStreet's ReactorNet
- Accorto Regulatory Solutions Partners with GINN for Tobacco Safety
- Opus IVS DrivePro 2 Achieves Motor Top 20 Award for 2024
- Autograph Revolutionizes Sports Fandom with New Platform
- Attain Capital Welcomes Former NASA CIO Renee P. Wynn
- ICEYE and Aon Join Forces to Boost Flood and Wildfire Response
- Laurence Moroney to Speak at Info-Tech LIVE 2024 Conference
- Philadelphia Fed Initiates Search for New President Following Harker
- Greece Stock Market Update: Athens Composite Dips Slightly
- Israel Stock Exchange Overview: TA 35 Declines Amid Sectors
- Oslo Stock Exchange Sees Subtle Gains, Led by Healthcare
- Why Freeport-McMoRan Is a Superior Investment Choice Today
Recent Articles
- Industrial Cooling Systems Market Set for Remarkable Growth
- NovoThelium Triumphs at Golden Ticket Pitch Competition
- Brugal Rum and Minute Maid Park: A Taste of the Caribbean
- Global Purchase Order Financing Market Growth to $12.9 Billion
- Enterprise Networking Market Projected to Reach $175.2 Billion
- FDB Honored as a Leading Workplace in the Bay Area
- MT Højgaard Holding A/S Announces Reduction in Shareholding
- Foundry Front Range Opens for Adult Behavioral Health Clients
- Dental Charting Software Market Expected to Surge by 2034
- Eric Hargan Joins Walnut Hill Medical's Board of Directors
- Discover Vult: Your Secure Private Cloud Storage Solution
- Westwood Hart Launches Innovative E-commerce Tailoring Platform
- Cell Therapy Market Projected to Reach USD 28.98 Billion by 2032
- NKF Launches Essential Online Education for Kidney Disease
- Ongoing Ozempic Shortages Impacting Europe into Q4 2024
- Amplify Assists Victims of Psychiatric Hospital Misconduct
- Green Logistics Market Surge: Growth to Reach USD 3.11 Trillion
- Worksport Ltd. Drives Growth with Innovative Tonneau Covers
- Symphony Talent Unveils SFX Brand Amplifier for Recruitment
- Arthur Hayes Predicts Bitcoin Price Could Hit $50,000
- ROCKWOOL A/S Announces Share Buyback Program Updates
- Uruguay's Tender Offer Results and Bond Purchasing Details
- Exertis and Seceon Join Forces with Fortress Security Service
- Lyft to Streamline Operations by Selling Bike and Scooter Assets
- Ocular Therapeutix to Showcase Innovations at Upcoming Events